000 02839cam a2200349 a 4500
003 EG-GiCUC
005 20250223031820.0
008 171004s2017 ua dh f m 000 0 eng d
040 _aEG-GiCUC
_beng
_cEG-GiCUC
041 0 _aeng
049 _aDeposite
097 _aPh.D
099 _aCai01.12.02.Ph.D.2017.Gh.E
100 0 _aGhada Hamdi Elsayed Mohamed
245 1 0 _aEffect of some newly synthesized steroid derivatives on apoptosis of breast cancer cells /
_cGhada Hamdi Elsayed Mohamed ; Supervised Rafat Milad Mohareb , Mervat Sayed Mohamed , Gamal Abdelmegeed Abdelghany
246 1 5 _aتأثير بعض المشتقات الستيرويدية الجديدة المشييدة على موت الخلايا المبرمج فى سرطان الثدى
260 _aCairo :
_bGhada Hamdi Elsayed Mohamed ,
_c2017
300 _a97 P. :
_bcharts , facsimiles ;
_c25cm
502 _aThesis (Ph.D.) - Cairo University - Faculty of Science - Department of Biochemistry
520 _aAnticancer agents consisting of hybrid molecules are used to improve effectiveness and diminish drug resistance. The current study aimed to introduce newly synthesized hetero-steroids of promising anticancer effects. Besides, the pro-apoptotic effects of new compounds were investigated extensively. Several pyrimidino-, triazolopyrimidino-, pyridazino-, and curcumin- steroid derivatives were synthesized, elucidated and confirmed using the spectral and analytical data. The synthesized hetero-steroids, compounds 9, 10, 11, 12, 13, 14, 15, 18, 20, 21, 22 and 24, were tested for their cytotoxic effects versus human breast cancer cells (MCF-7) using neutral red supravital dye uptake assay. Compound 24 (IC50 = 18 æM) showed more inhibitory influence on MCF-7 growth. Using QRT-PCR (Quantitative real time-polymerase chain reaction), CCND1, Survivin, BCL-2, CDC2, P21 and P53, genes expression levels were investigated. The study results disclose that compounds 4, 7, 18, 24 knocked down the expression levels of CCND1, Survivin, BCL-2 and CDC2. However, P21 and P53 were up- regulated by compounds 21, 22. This study introduced promising pro-apoptotic anticancer agents acting through the modulation of key regulators of apoptosis and cell cycle genes. The current study revealed the most promising compounds 7, 18, 21 down-regulated miR-34a, miR-98 and miR-214 expression levels and decreased upon drug resistance response.
530 _aIssued also as CD
653 4 _aBreast cancer
653 4 _aHeterocycles
653 4 _aSteroids
700 0 _aGamal Abdelmegeed Abdelghany ,
_eSupervisor
700 0 _aMervat Sayed Mohamed ,
_eSupervisor
700 0 _aRafat Milad Mohareb ,
_eSupervisor
856 _uhttp://172.23.153.220/th.pdf
905 _aNazla
_eRevisor
905 _aShimaa
_eCataloger
942 _2ddc
_cTH
999 _c62752
_d62752